Bashti Malek, Daftari Manav, Brusko Gregory D, Jamshidi Aria M, Singh Eric B, Boddu James V, Kumar Vignessh, Yang Michael M H, Wang Michael Y
Department of Neurosurgery, Miller School of Medicine, University of Miami, Miami, FL, USA
Department of Neurosurgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Int J Spine Surg. 2024 Jul 4;18(3):295-303. doi: 10.14444/8599.
Adjacent segment disease (ASD) is a known sequela of thoracolumbar instrumented fusions. Various surgical options are available to address ASD in patients with intractable symptoms who have failed conservative measures. However, the optimal treatment strategy for symptomatic ASD has not been established. We examined several clinical outcomes utilizing different surgical interventions for symptomatic ASD.
A retrospective review was performed for a consecutive series of patients undergoing revision surgery for thoracolumbar ASD between October 2011 and February 2022. Patients were treated with endoscopic decompression ( = 17), microdiscectomy ( = 9), lateral lumbar interbody fusion (LLIF; = 26), or open laminectomy and fusion (LF; = 55). The primary outcomes compared between groups were re-operation rates and numeric pain scores for leg and back at 2 weeks, 10 weeks, 6 months, and 12 months postoperation. Secondary outcomes included time to re-operation, estimated blood loss, and length of stay.
Of the 257 patients who underwent revision surgery for symptomatic ASD, 107 patients met inclusion criteria with a minimum of 1-year follow-up. The mean age of all patients was 67.90 ± 10.51 years. There was no statistically significant difference between groups in age, gender, preoperative American Society of Anesthesiologists scoring, number of previously fused levels, or preoperative numeric leg and back pain scores. The re-operation rates were significantly lower in LF (12.7%) and LLIF cohorts (19.2%) compared with microdiscectomy (33%) and endoscopic decompression (52.9%; = 0.005). Only LF and LLIF cohorts experienced significantly decreased pain scores at all 4 follow-up visits (2 weeks, 10 weeks, 6 months, and 12 months; < 0.001 and < 0.05, respectively) relative to preoperative scores.
Symptomatic ASD often requires treatment with revision surgery. Fusion surgeries (either stand-alone lateral interbody or posterolateral with instrumentation) were most effective and durable with respect to alleviating pain and avoiding additional revisions within the first 12 months following revision surgery.
This study emphasizes the importance of risk-stratifying patients to identify the least invasive approach that treats their symptoms and reduces the risk of future surgeries.
相邻节段疾病(ASD)是胸腰椎器械融合术已知的后遗症。对于保守治疗失败且症状顽固的ASD患者,有多种手术选择可供治疗。然而,有症状ASD的最佳治疗策略尚未确立。我们研究了使用不同手术干预方法治疗有症状ASD的几种临床结果。
对2011年10月至2022年2月期间连续接受胸腰椎ASD翻修手术的一系列患者进行回顾性研究。患者接受了内镜减压术(n = 17)、显微椎间盘切除术(n = 9)、腰椎侧方椎间融合术(LLIF;n = 26)或开放性椎板切除术和融合术(LF;n = 55)。比较组间的主要结果是再手术率以及术后2周、10周、6个月和12个月时腿部和背部的数字疼痛评分。次要结果包括再手术时间、估计失血量和住院时间。
在257例接受有症状ASD翻修手术的患者中,107例患者符合纳入标准并进行了至少1年的随访。所有患者的平均年龄为67.90±10.51岁。组间在年龄、性别、术前美国麻醉医师协会评分、既往融合节段数或术前腿部和背部数字疼痛评分方面无统计学显著差异。与显微椎间盘切除术(33%)和内镜减压术(52.9%;P = 0.005)相比,LF组(12.7%)和LLIF组(19.2%)的再手术率显著更低。相对于术前评分,只有LF组和LLIF组在所有4次随访(2周、10周、6个月和12个月)时疼痛评分均显著降低(分别为P < 0.001和P < 0.05)。
有症状的ASD通常需要翻修手术治疗。融合手术(单独的侧方椎间融合或带器械的后外侧融合)在缓解疼痛和避免翻修手术后的前12个月内再次翻修方面最为有效和持久。
本研究强调了对患者进行风险分层以确定治疗其症状并降低未来手术风险的侵入性最小方法的重要性。